Erythroblastosis fetalis (hemolytic disease of the newborn) occurs when an Rh-negative mother carries an Rh-positive fetus. During delivery or placental disruption, fetal Rh-positive RBCs enter maternal circulation, triggering antibody production. In subsequent pregnancies, these antibodies attack fetal RBCs.